Changing the treatment of permanent neonatal diabetes mellitus from insulin to glibenclamide in a 4-month-old infant with kcnj11 activating mutation

Permanent neonatal diabetes mellitus (PNDM) is a rare type of diabetes and KCNJ11 gene activating mutation is one of its prevalent causes. We introduced a 4-month-old male infant with poor feeding, restlessness, tachypnea, hyperglycemia, metabolic acidosis, and ketonemia. He was discharged with insu...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Homa Ilkhanipoor, Zohreh Karamizadeh
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Wolters Kluwer Medknow Publications 2013-01-01
Schriftenreihe:	International Journal of Preventive Medicine
Schlagworte:	KCNJ11 permanent neonatal diabetes mellitus sulfonylurea
Online-Zugang:	http://www.ijpvmjournal.net/article.asp?issn=2008-7802;year=2013;volume=4;issue=9;spage=1078;epage=1081;aulast=Ilkhanipoor
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!